Exome Sequencing Implicates DGKZ , ESRRA , and GXYLT1 for Modulating Granuloma Formation in Crohn Disease

J Pediatr Gastroenterol Nutr. 2023 Sep 1;77(3):354-357. doi: 10.1097/MPG.0000000000003873. Epub 2023 Jun 22.

Abstract

Non-caseating granulomas may indicate a more aggressive phenotype of Crohn disease (CD). Genetic associations of granulomatous CD (GCD) may help elucidate disease pathogenesis. Whole-exome sequencing was performed on peripheral blood-derived DNA from 17 pediatric patients with GCD and 19 with non-GCD (NGCD), and from an independent validation cohort of 44 GCD and 19 NGCD cases. PLINK (a tool set for whole-genome association and population-based linkage analyses) analysis was used to identify single nucleotide polymorphisms (SNPs) differentiating between groups, and subgroup allele frequencies were also compared to a public genomic database (gnomAD). The Combined Annotation Dependent Depletion scoring tool was used to predict deleteriousness of SNPs. Human leukocyte antigen (HLA) haplotype findings were compared to a control group (n = 8496). PLINK-based analysis between GCD and NGCD groups did not find consistently significant hits. gnomAD control comparisons, however, showed consistent subgroup associations with DGKZ , ESRRA , and GXYLT1 , genes that have been implicated in mammalian granulomatous inflammation. Our findings may guide future research and precision medicine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Child
  • Crohn Disease* / complications
  • ERRalpha Estrogen-Related Receptor
  • Exome Sequencing
  • Genetic Predisposition to Disease
  • Granuloma / genetics
  • Granuloma / pathology
  • Humans
  • Phenotype

Substances

  • GXYLT1 protein, human
  • DGKZ protein, human